Low-dose CT (LDCT) for lung cancer screening commonly identifies findings outside the lungs’ primary screening targets. These incidental findings (IFs) can be clinically useful but also carry risks of overdiagnosis, unnecessary investigations, interventions, and increased healthcare costs. The present study examined the clinical urgency of IFs detected in the first year of the Dutch arm of the 4-IN-THE-LUNG-RUN screening program, determining how often IFs prompted communication to primary care, further diagnostic work-up, or urgent intervention.
Participants in the Dutch arm of the 4-IN-THE-LUNG-RUN program who completed baseline and first annual LDCT screening between December 2022 and May 2025 were included for analysis. The cohort comprised 4,122 participants, of whom 56.5% were male and the median age was 68 years.
Radiologist reports were reviewed to identify described IFs. A centralized expert adjudication panel then assessed the clinical urgency of these reported IFs and categorized subsequent management actions, including whether the IF was communicated to primary care, referred for further diagnostic work-up, or required (urgent) referral or intervention.
At the annual screening, the study assessed the longitudinal behavior of previously reported IFs and classified them as new, stable, progressing, or surgically intervened to capture change over time and any resulting procedures.
Radiologist-described IFs from both baseline and annual scans were collated. Centralized expert adjudication determined which IFs warranted reporting to primary care or onward referral. The adjudication process served to standardize decisions about clinical urgency across the cohort and to quantify the downstream actions taken because of IF detection.
Across both screening rounds, radiologists described IFs in 291 participants, representing 7.1% of the 4,122 screened individuals. Following centralized adjudication, 75 participants (1.8% of the cohort) had an IF formally reported to primary care. Of the adjudicated IFs, 19 participants (0.5% of the cohort) were referred for further clinical work-up.
Focusing on the baseline screening round, the abstract reports that 67 IFs in 58 participants (1.4%) were reported to primary care. Ten of those baseline-reported IFs were referred for clinical work-up. The abstract text in the provided source is truncated at this point and stops mid-sentence when listing example outcomes; therefore, additional specifics about the nature of these baseline referrals, the single example that begins to be named, or subsequent management details are not available in the excerpt.
At the annual (first-year) screening, the study evaluated the prior IFs for change over time. Each previously reported IF was classified into one of four longitudinal categories: new, stable, progressing, or surgically intervened. This approach allowed the investigators to quantify how frequently IFs evolved in a manner that might alter clinical management and to identify IFs that ultimately required surgical treatment.
The provided abstract confirms that this classification was performed but the detailed counts for each category (new, stable, progressing, surgically intervened) and any associated clinical consequences are not fully reported in the available text.
In the first year of the Dutch 4-IN-THE-LUNG-RUN LDCT lung cancer screening program, IFs were described in a minority of participants (7.1%). After expert adjudication, an even smaller proportion required communication to primary care (1.8%) or further diagnostic referral (0.5%). These findings suggest that while IFs are a recognized consequence of LDCT screening, only a small fraction of screened individuals required additional evaluation or referral based on adjudicated clinical urgency.
This balance—potential incidental detection of clinically relevant nonpulmonary disease versus the risk of overdiagnosis and increased downstream healthcare use—remains a central consideration when implementing population-based LDCT screening programs.
The summary available from the PubMed/NCBI source is truncated. Key details not reported in the provided excerpt include the specific types and anatomic distribution of IFs, the precise numbers of IFs classified as new/stable/progressing/surgically intervened at annual screening, the nature and outcomes of the referred work-ups, any urgent interventions performed, and longer-term clinical consequences for participants. Where the abstract cuts off mid-sentence, the original full-text article would need to be consulted for complete results, detailed subgroup analyses, and the authors’ full discussion and conclusions.
Overall, the available abstract provides clear cohort counts and core adjudicated outcome rates but leaves several clinically relevant outcome details unreported in the excerpt provided.